ACER: Merged with Zevra Therapeutics, Inc.; ACER shareholders will receive 0.1210 shares of ZVRA for every 1 share of ACER held and one non-transferable contingent value right representing the right to receive one or more contingent payments, if any, upon the achievement of certain milestones, as set forth in the Contingent Value Rights Agreement.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.